載入...

Plasmablastic lymphoma after standard-dose temozolomide for newly diagnosed glioblastoma

Secondary malignancies due to alkylating agents or topoisomerase II inhibitors are a concern in patients treated for primary brain tumors of the nervous system. Myelosuppression is the dose-limiting toxic effect of the alkylating agent temozolomide; reversible hematologic toxicity consisting mainly...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Clark, Stephen W., Taylor, Jennie, Wang, Daphne L., Abramson, Jeremy S., Batchelor, Tracy T.
格式: Artigo
語言:Inglês
出版: Lippincott Williams & Wilkins 2013
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3770207/
https://ncbi.nlm.nih.gov/pubmed/23685934
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e318297eea6
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!